Key Statistics for 2877
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (CNY) (ttm)
|Est. EPS (CNY) (12/2013)
|Est. PEG Ratio
|Market Cap (M HKD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (CNY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 2877
- Net Income (M/CNY)
China Shineway Pharmaceutical Group Limited develops, manufactures, and sells modern Chinese medicines in the Peoples Republic of China. The Company also produces and sells a series of western pharmaceuticals.
More Company Profile & Key Executives for 2877
|Li ZhenjiangChairman/President||Wang ZhihuaExec Dir/Co-Founder|
|Xin YunxiaExec Dir/Co-Founder||Li HuiminExecutive Director|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.